Item request has been placed!
×
Item request cannot be made.
×
Processing Request
State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Kim RB;Kim RB; Irvin CW; Irvin CW; Tilva KR; Tilva KR; Mitchell CS; Mitchell CS
- المصدر:
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2015; Vol. 17 (1-2), pp. 1-14. Date of Electronic Publication: 2015 May 22.
- نوع النشر :
Journal Article; Research Support, N.I.H., Extramural; Review; Systematic Review
- اللغة:
English
- معلومة اضافية
- المصدر:
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101587185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2167-9223 (Electronic) Linking ISSN: 21678421 NLM ISO Abbreviation: Amyotroph Lateral Scler Frontotemporal Degener Subsets: MEDLINE
- بيانات النشر:
Publication: 2015- : Abingdon, Oxford : Taylor & Francis
Original Publication: Colchester, Essex : Informa Healthcare
- الموضوع:
- نبذة مختصرة :
Numerous sub-cellular through system-level disturbances have been identified in over 1300 articles examining the superoxide dismutase-1 guanine 93 to alanine (SOD1-G93A) transgenic mouse amyotrophic lateral sclerosis (ALS) pathophysiology. Manual assessment of such a broad literature base is daunting. We performed a comprehensive informatics-based systematic review or 'field analysis' to agnostically compute and map the current state of the field. Text mining of recaptured articles was used to quantify published data topic breadth and frequency. We constructed a nine-category pathophysiological function-based ontology to systematically organize and quantify the field's primary data. Results demonstrated that the distribution of primary research belonging to each category is: systemic measures an motor function, 59%; inflammation, 46%; cellular energetics, 37%; proteomics, 31%; neural excitability, 22%; apoptosis, 20%; oxidative stress, 18%; aberrant cellular chemistry, 14%; axonal transport, 10%. We constructed a SOD1-G93A field map that visually illustrates and categorizes the 85% most frequently assessed sub-topics. Finally, we present the literature-cited significance of frequently published terms and uncover thinly investigated areas. In conclusion, most articles individually examine at least two categories, which is indicative of the numerous underlying pathophysiological interrelationships. An essential future path is examination of cross-category pathophysiological interrelationships and their co-correspondence to homeostatic regulation and disease progression.
- References:
Exp Neurol. 2000 Sep;165(1):184-90. (PMID: 10964497)
Amyotroph Lateral Scler Other Motor Neuron Disord. 2002 Jun;3(2):75-85. (PMID: 12215229)
Nat Med. 2004 Apr;10(4):402-5. (PMID: 15034571)
Neurobiol Dis. 2010 Feb;37(2):370-83. (PMID: 19874893)
PLoS One. 2013;8(2):e30243. (PMID: 23405058)
Mech Ageing Dev. 2010 Jul-Aug;131(7-8):517-26. (PMID: 20493207)
Amino Acids. 2011 May;40(5):1305-13. (PMID: 21448659)
J Mol Biol. 2008 Oct 24;382(5):1195-210. (PMID: 18706911)
J Neurochem. 1999 Dec;73(6):2460-8. (PMID: 10582606)
J Neuromuscul Dis. 2015;2(2):137-150. (PMID: 26594635)
Neuron. 1995 Jun;14(6):1105-16. (PMID: 7605627)
Brain Res. 2000 Oct 6;879(1-2):183-7. (PMID: 11011020)
J Physiol. 2005 Mar 15;563(Pt 3):843-54. (PMID: 15649979)
J Neurol Sci. 2010 Mar 15;290(1-2):41-7. (PMID: 20060132)
J Neurosci. 2006 Nov 1;26(44):11397-402. (PMID: 17079668)
Free Radic Biol Med. 2011 Jul 1;51(1):88-96. (PMID: 21457778)
Neurobiol Dis. 2006 Jun;22(3):599-610. (PMID: 16616851)
Neuropharmacology. 2011 Jun;60(7-8):1200-8. (PMID: 21056589)
J Physiol. 2011 May 1;589(Pt 9):2245-60. (PMID: 21486770)
Muscle Nerve. 1995 Jul;18(7):741-52. (PMID: 7783764)
J Neurotrauma. 2008 Dec;25(12):1483-97. (PMID: 19125684)
PLoS One. 2011;6(8):e22374. (PMID: 21829620)
Nat Rev Neurosci. 2013 Apr;14(4):248-64. (PMID: 23463272)
Neurobiol Dis. 2010 Mar;37(3):493-502. (PMID: 19833209)
J Cell Biol. 2005 May 23;169(4):561-7. (PMID: 15911875)
J Neurophysiol. 2009 Dec;102(6):3627-42. (PMID: 19828728)
Neural Netw. 2003 Nov;16(9):1277-92. (PMID: 14622884)
Science. 2000 Apr 14;288(5464):335-9. (PMID: 10764647)
Mol Pharmacol. 2009 Mar;75(3):478-89. (PMID: 19060114)
Lancet Neurol. 2011 Mar;10(3):253-63. (PMID: 21349440)
Neurodegener Dis. 2005;2(3-4):147-59. (PMID: 16909020)
Neurobiol Dis. 2000 Aug;7(4):406-15. (PMID: 10964611)
J Biol Chem. 2009 May 15;284(20):13291-5. (PMID: 19182219)
Neurol Res. 2002 Sep;24(6):577-81. (PMID: 12238624)
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13046-50. (PMID: 20616033)
J Neurol Sci. 2006 Dec 21;251(1-2):44-9. (PMID: 17049562)
J Pharmacol Exp Ther. 2006 Jan;316(1):189-99. (PMID: 16188953)
Free Radic Biol Med. 2010 Mar 1;48(5):629-41. (PMID: 19969067)
Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1051-67. (PMID: 16713195)
Neuroscience. 2013 Jan 29;230:94-101. (PMID: 23178912)
Brain. 2005 Jul;128(Pt 7):1686-706. (PMID: 15872021)
Biochim Biophys Acta. 2010 Jan;1802(1):45-51. (PMID: 19715760)
Acta Biochim Pol. 2013;60(1):51-5. (PMID: 23460941)
J Theor Biol. 2012 May 7;300:277-91. (PMID: 22285784)
Nat Neurosci. 1999 Jan;2(1):50-6. (PMID: 10195180)
J Neurosci. 2005 Jan 5;25(1):164-72. (PMID: 15634778)
J Neurol Sci. 2000 Feb 1;173(1):53-62. (PMID: 10675580)
Lancet. 2011 Mar 12;377(9769):942-55. (PMID: 21296405)
Brain Res Mol Brain Res. 2003 Mar 17;111(1-2):155-64. (PMID: 12654515)
J Theor Biol. 2009 Apr 7;257(3):430-7. (PMID: 19150364)
J Neurosci Res. 2004 Oct 15;78(2):193-9. (PMID: 15378612)
Neuropharmacology. 2004 May;46(6):782-92. (PMID: 15033338)
J Alzheimers Dis. 2015;44(3):787-95. (PMID: 25362040)
J Neurosci. 2010 Apr 21;30(16):5544-58. (PMID: 20410108)
J Neurochem. 2003 Jun;85(5):1324-35. (PMID: 12753090)
Neurosci Res. 2008 Oct;62(2):71-7. (PMID: 18656504)
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17913-8. (PMID: 18997009)
FEBS Lett. 2010 Apr 16;584(8):1615-22. (PMID: 20303959)
J Neurochem. 2010 Apr;113(2):489-501. (PMID: 20132478)
Neurobiol Dis. 2006 Jan;21(1):110-8. (PMID: 16084734)
J Neurochem. 2011 Mar;116(6):1028-42. (PMID: 21175617)
J Neurochem. 2005 Apr;93(1):38-46. (PMID: 15773903)
Biochim Biophys Acta. 2010 May;1802(5):462-71. (PMID: 20097285)
Eur J Neurosci. 2008 Oct;28(7):1275-85. (PMID: 18973555)
Cell Calcium. 2010 Feb;47(2):165-74. (PMID: 20116097)
J Biol Chem. 2007 Sep 21;282(38):28087-95. (PMID: 17666395)
Eur J Neurosci. 2004 Dec;20(11):3179-83. (PMID: 15579172)
J Neurosci. 2006 Aug 23;26(34):8774-86. (PMID: 16928866)
Neurosci Lett. 2002 Jun 7;325(2):124-8. (PMID: 12044637)
Eur J Neurosci. 2007 Mar;25(6):1669-77. (PMID: 17432958)
J Theor Biol. 2015 Apr 7;370:39-44. (PMID: 25615423)
J Neurophysiol. 2011 Mar;105(3):1170-8. (PMID: 21191091)
J Physiol. 2006 Aug 1;574(Pt 3):819-34. (PMID: 16728453)
J Neurosci. 1998 Dec 1;18(23):9673-84. (PMID: 9822728)
Trends Mol Med. 2004 Jan;10(1):1-3. (PMID: 14720577)
Neurodegener Dis. 2015;15(2):109-13. (PMID: 25720304)
J Neurochem. 2008 Feb;104(4):993-1005. (PMID: 18233996)
J Biol Chem. 2008 May 16;283(20):13528-37. (PMID: 18316367)
Hum Mol Genet. 2007 Nov 15;16(22):2720-8. (PMID: 17725983)
Brain Res. 2006 Apr 14;1083(1):196-203. (PMID: 16546142)
Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1068-82. (PMID: 16806844)
J Neuroimmunol. 2010 Dec 15;229(1-2):51-62. (PMID: 20659772)
J Biol Chem. 2011 Jan 28;286(4):2795-806. (PMID: 21068388)
Amyotroph Lateral Scler. 2010;11(1-2):83-90. (PMID: 19452308)
J Physiol. 2014 Apr 1;592(7):1687-703. (PMID: 24445319)
Muscle Nerve. 2005 Jul;32(1):43-50. (PMID: 15880561)
Antioxid Redox Signal. 2012 Nov 15;17(10):1333-50. (PMID: 22563797)
- Grant Information:
K01 NS069616 United States NS NINDS NIH HHS; R21 NS081426 United States NS NINDS NIH HHS; NS069616 United States NS NINDS NIH HHS; NS081426 United States NS NINDS NIH HHS
- Contributed Indexing:
Keywords: Mitochondria; calcium; excitotoxicity; gliosis; neuropathology; protein aggregation; reactive oxygen species; rotarod
- الرقم المعرف:
0 (Genetic Markers)
0 (Proteome)
EC 1.15.1.1 (SOD1 G93A protein)
EC 1.15.1.1 (Superoxide Dismutase)
- الموضوع:
Date Created: 20150523 Date Completed: 20161019 Latest Revision: 20181202
- الموضوع:
20250114
- الرقم المعرف:
PMC4724331
- الرقم المعرف:
10.3109/21678421.2015.1047455
- الرقم المعرف:
25998063
No Comments.